Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

You have to screen for dividend durability and reliability ... holding a microscope and reflecting on the diagnosis of a patient. Viatris Inc. (NASDAQ:VTRS) is a Pennsylvania-based pharmaceutical ...

This leaflet answers some common questions about AZITHROMYCIN VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of ...

This leaflet answers some common questions about ENTECAVIR VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Shares of Viatris Inc. VTRS shed 0.33% to $11.96 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.16% to 5,918.25 ...

Shares of Viatris Inc. VTRS dropped 0.68% to $11.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.11% to 5,842.91 ...